Company profile: Predilife
1.1 - Company Overview
Company description
- Provider of predictive medicine solutions that combine proven medical techniques (genetic testing, medical imaging) with mathematical models and extensive statistical data to assess individual risk profiles for serious diseases. Offers a breast cancer five-year risk assessment with personalized follow-up and recommendations, and multi-pathology assessments for major cancers and cardiovascular diseases.
Products and services
- Predictive Medicine Systems: Predilife engineers clinical-grade systems combining genetic testing and medical imaging with mathematical models trained on large statistical datasets to ascertain individual risk profiles across many serious diseases
- Bilan prédictif multi-pathologies: Predilife delivers risk-stratified assessment for men and women evaluating risks of major cancers and cardiovascular diseases, with tailored medical follow-up based on individual risk
- Bilan prédictif du cancer du sein: Predilife offers time-bound assessment estimating a woman’s five-year breast cancer risk, with personalized recommendations and follow-up tailored to her risk profile
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Predilife
Perspective Therapeutics
HQ: United States
Website
- Description: Provider of radiopharmaceutical cancer theranostics and targeted alpha-particle radiotherapy, including Pb-203 diagnostics and Pb-212 treatment via targeting peptides. Offers clinical programs VMT-α-NET for neuroendocrine tumors and VMT01 for metastatic melanoma, and a proprietary Pb-212 isotope generator to secure key isotopes for clinical trials and commercial operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perspective Therapeutics company profile →
Acerta Pharma
HQ: United States
Website
- Description: Provider of oncology and autoimmune drug discovery and development, including CALQUENCE (acalabrutinib) for CLL; collaborative small-molecule discovery for hematologic malignancies; innovative clinical studies; resistance biology research using multi-omic profiling; R&D on target identification and optimization; and partnering and in-licensing opportunities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acerta Pharma company profile →
ScreenPoint Medical
HQ: The Netherlands
Website
- Description: Provider of deep learning and image analysis technology for automated reading of mammograms and digital breast tomosynthesis. Offers Transpara software that assists radiologists by categorizing and prioritizing exams, differentiating those with a high probability of suspicious findings, and providing workflow enhancements, combining machine learning advances with very large, well-curated digital image databases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ScreenPoint Medical company profile →
Clinical Laserthermia Systems
HQ: Sweden
Website
- Description: Provider of the TRANBERG® Thermal Therapy System and disposable materials for image-guided, minimally invasive laser ablation and heat-induced immunotherapy (imILT®), offering focal therapy for localized prostate cancer, careful therapy of brain lesions/epileptogenic foci, immune-stimulating laser ablation, and the Thermoguide Workstation for real-time treatment monitoring and control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Laserthermia Systems company profile →
AVEO Oncology
HQ: United States
Website
- Description: Provider of targeted cancer therapeutics and oncology development platforms. Products include FOTIVDA (tivozanib), an oral VEGFR TKI approved for relapsed/refractory advanced RCC. Pipeline includes ficlatuzumab (anti-HGF) for HNSCC, AV-380 (anti-GDF15) for cancer cachexia, and AV-203, a HER3 inhibitory antibody. Offers an integrated cancer biology and Human Response platform for efficient discovery and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AVEO Oncology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Predilife
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Predilife
2.2 - Growth funds investing in similar companies to Predilife
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Predilife
4.2 - Public trading comparable groups for Predilife
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →